Renaissance Group’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$934K Sell
4,994
-134
-3% -$24.6K 0.04% 163
2026
Q1
$968K Sell
5,128
-487
-9% -$103K 0.04% 155
2025
Q4
$1.12M Sell
5,615
-33
-0.6% -$6.67K 0.04% 144
2025
Q3
$1.15M Buy
5,648
+3,771
+201% +$669K 0.04% 150
2025
Q2
$330K Sell
1,877
-243
-11% -$36.6K 0.01% 204
2025
Q1
$285K Buy
+2,120
New +$279K 0.01% 216
2024
Q4
Sell
-2,152
Closed -$358K 258
2024
Q3
$358K Buy
+2,152
New +$325K 0.01% 208

Other funds holding THC

Renaissance Group's THC Position: Q2 2026 in Review

Renaissance Group reduced its Tenet Healthcare (THC) stake by 2.6% in Q2 2026, selling an estimated $24.6K and leaving 4,994 shares worth $934K. The position accounts for 0.04% of the portfolio, ranked #163.

Renaissance Group first reported a position in THC in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.15M in Q3 2025. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Renaissance Group held 4,994 shares of Tenet Healthcare worth $934K as of Q2 2026.
  • Renaissance Group sold 134 Tenet Healthcare shares in Q2 2026, an estimated $24.6K.
  • Tenet Healthcare made up 0.04% of Renaissance Group's portfolio in Q2 2026, its #163 holding.
  • Renaissance Group first reported a position in Tenet Healthcare in Q3 2024 and has held it in 7 quarters since.
  • Renaissance Group's Tenet Healthcare position peaked at $1.15M in Q3 2025.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Renaissance Group's 13F filing for Q2 2026, filed 13 Aug 2026.